Cargando…

Clinical outcomes of patients with metachronous second primary lung adenocarcinomas

BACKGROUND: The incidence of adenocarcinomas as multiple primary lung cancers (MPLCs) is increasing. How to determine the treatment strategies of MPLCs, especially second primary lung adenocarcinomas (SPLACs), and the prognostic factors associated with it are unclear. METHODS: The clinical records o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Heng, Yang, Haitang, Han, Ke, Xu, Jianlin, Yao, Feng, Zhao, Yang, Fan, Liwen, Gu, Haiyong, Shen, Zhenya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237587/ https://www.ncbi.nlm.nih.gov/pubmed/28138252 http://dx.doi.org/10.2147/OTT.S122908

Ejemplares similares

Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection
por: Fan, Liwen, et al.
Publicado: (2017)

Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
por: Fan, Liwen, et al.
Publicado: (2021)

Radiotherapy was associated with the lower incidence of metachronous second primary lung cancer
por: Hu, Zhi Gang, et al.
Publicado: (2019)

Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations
por: Hu, Yan, et al.
Publicado: (2020)

Establishing a TNM-like risk classification for metachronous second pulmonary adenocarcinoma in patients with previously resected pulmonary adenocarcinoma
por: Fu, Shen-Shen, et al.
Publicado: (2022)

Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors
por: Hu, Zhi Gang, et al.
Publicado: (2018)

Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors
por: Yang, Haitang, et al.
Publicado: (2022)

Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma
por: Chen, Jianing, et al.
Publicado: (2023)

Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis()()
por: Saab, Jad, et al.
Publicado: (2017)

Multi-scale integrative analyses identify THBS2(+) cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma
por: Yang, Haitang, et al.
Publicado: (2022)

Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report
por: Yao, Shuyang, et al.
Publicado: (2021)

A Case of Metastatic Non-small Cell Lung Adenocarcinoma and Metachronous Primary Hepatocellular Carcinoma
por: Sidhom, Fady, et al.
Publicado: (2021)

Prognostic Nomogram and Therapeutic Option of Cancer-Specific Death in the Patients with Metachronous Second Primary Lung Cancer
por: Wang, Jiahui, et al.
Publicado: (2022)

Establishing a prognostic model for metachronous second squamous cell lung cancer in patients with resected squamous cell lung cancer
por: Fu, Shen-Shen, et al.
Publicado: (2022)

Metachronous Primary Adenocarcinoma of Distal and Proximal Ureter within Two Years
por: Abt, Dominik, et al.
Publicado: (2014)

Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes
por: Luo, Xi, et al.
Publicado: (2022)

Clear cell adenocarcinoma of the prostatic urethra with metachronous prostate adenocarcinoma
por: Wang, Henry, et al.
Publicado: (2023)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors
por: Lv, Meng, et al.
Publicado: (2017)

Leiomyosarcoma as a Second Metachronous Malignant Neoplasm Following Colon Adenocarcinoma. A Case Report and Review of the Literature
por: Mavrodontidis, A., et al.
Publicado: (2001)

Metachronous Multiple Primary Carcinoma With Acute Promyelocytic Leukemia: 2 Cases Report and Literature Review
por: Wang, Cong, et al.
Publicado: (2022)

Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer: a population-based study
por: Zhang, Rusi, et al.
Publicado: (2020)

Comparison of outcomes of tyrosine kinase inhibitor in first- or second-line therapy for advanced non-small-cell lung cancer patients with sensitive EGFR mutations
por: Xu, Jianlin, et al.
Publicado: (2016)

Neoadjuvant immunotherapy facilitates resection of surgically-challenging lung squamous cell cancer
por: Xu, Ke, et al.
Publicado: (2021)

Metachronous Primary Adenocarcinoma of Lung During Adjuvant Imatinib Mesylate Therapy for Gastrointestinal Stromal Tumor of Stomach: A Case Report
por: Jiang, Meng-jie, et al.
Publicado: (2015)

S100A14 rs11548103 G>A polymorphism is associated with a decreased risk of esophageal cancer in a Chinese population
por: Zhao, Yang, et al.
Publicado: (2017)

Visceral pleural invasion predict a poor survival among lung adenocarcinoma patients with tumor size ≤ 3cm
por: Chen, Tianxiang, et al.
Publicado: (2017)

Restrictive Ventilatory Impairment as a Poor Prognostic Factor in Patients Who Undergo Surgical Resection for Metachronous Second Primary Lung Cancer
por: Komatsu, Hiroaki, et al.
Publicado: (2023)

Metachronous adenocarcinoma of the anal canal after anterior resection for sporadic primary rectal adenocarcinoma: A rare case report
por: Gaertner, Wolfgang B., et al.
Publicado: (2014)

Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma
por: Zhang, Chao, et al.
Publicado: (2018)

Metachronous small bowel adenocarcinoma after rectal adenocarcinoma: A case report
por: Zhen, Ya’nan, et al.
Publicado: (2021)

Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasound
por: Jia, Wan-Ying, et al.
Publicado: (2023)

Genetic Profiling Differentiates Second Primary Tumors from Metastases in Adult Metachronous Soft Tissue Sarcoma
por: Fernebro, Josefin, et al.
Publicado: (2008)

Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010)
por: Jung, Yuh-S, et al.
Publicado: (2015)

Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?
por: Adeel, Mohammad, et al.
Publicado: (2018)

Metachronous triple primary neoplasms with primary prostate cancer, lung cancer, and colon cancer: A case report
por: Feng, Yuhua, et al.
Publicado: (2018)

Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis
por: Li, Yue, et al.
Publicado: (2022)

Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinoma
por: El Hajj, Ihab I., et al.
Publicado: (2018)

Metachronous double primary neuroendocrine tumors in larynx and lung: a case report
por: Song, In Hye, et al.
Publicado: (2020)

The pattern of metachronous recurrence after endoscopic submucosal dissection for gastric adenocarcinoma and dysplasias
por: Suk, Sunah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c447946q8q7phgsq994vt5q21v